Ormeloxifene- A new treatment modality in Dysfunctional Uterine Bleeding: efficacy and safety

Journal Title: Indian Journal of Obstetrics and Gynecology Research - Year 2016, Vol 3, Issue 3

Abstract

Background/ Objective: To compare the efficacy and safety of ormeloxifene and norethisterone in the medical management of Dysfunctional Uterine Bleeding (DUB). Methods: 100 cases of DUB aged between 30 to 50years, who have completed child bearing, were randomly assigned ormeloxifene and Norethisterone groups. Ormeloxifene group received ormeloxifene 60 mg twice a week for 12 weeks and then once a week for next 12 weeks. Norethisterone group received norethisterone 5 mg twice daily for 21 days in every cycle for six cycles. Patients were followed up at end of 3rd and 6th month of therapy, and then at the end of 3rd month after treatment were stopped. The treatment with ormeloxifene and Norethisterone was evaluated by measuring the menstrual blood loss (MBL) by a pictorial blood loss assessment chart (PBAC), Hb g/dl and the endometrial thickness before and after 3 months of treatment. The side effects and patient acceptability of drug ormeloxifene were compared with norethisterone. Results: The mean PBAC score and Endometrial thickness (ET) in Norethisterone group and ormeloxifen group reduced significantly (P-value <0.0001) at the end of 3rd month after treatment were stopped. The Hb level increased maximum in Ormeloxifen group followed by Norethisterone group significantly (p<0.0001). In Norethisterone group side effects were hypomenorrhoea, spotting and breakthrough bleeding. In Ormeloxifen group side effects were amenorrhoea, hypomenorrhoea, spotting, Utero-vaginal prolapse. Conclusion: Ormeloxifene is more effective and safe therapeutic option as compared to Norethisterone for the medical management of DUB.

Authors and Affiliations

Sanchita Karmakar, Hemant Deshpande

Keywords

Related Articles

Neurological disorders during pregnancy and puerperium-still a significant cause of maternal morbidity and mortality in Rural India

Introduction: A variety of neurological disorders may be encountered during pregnancy and puerperium. These disorders may be unrelated to the pregnant state (e.g., tuberculous meningitis) or peculiar to or more prevalent...

A clinical review of emergency obstetric hysterectomy

Objective: To evaluate risk factors, incidence, indication, maternal and fetal outcome in patients undergoing emergency obstetric hysterectomy in a tertiary care center. Materials and Method: It is a retrospective study...

Evaluation of efficacy, safety and cost effectiveness of oral iron and injectable iron sucrose and ferric carboxy maltose in pregnant women in 2nd and 3rd trimester in anaemia

Objective: To compare the efficacy safety and cost effective of oral iron and injectable iron sucrose and FCM in pregnancy in 2nd and 3rd trimester. Methods: A prospective randomised control trial study in 300 women with...

Study of postpartum depression and association with obstetrics risk factors

Aim and Objectives To know the prevalence of postpartum depression by Edinburgh postnatal depression scale and evaluate the obstetrics risk factors which predisposing to postpartum depressionMaterial and Methods The pres...

Interesting phenomenon of Concomitant Leiomyomas: Management issues in a two case miniseries

Vaginal fibroids with coincidental uterine fibroids are very occurrences in gynaceological practice. They tend to pose management difficulties with regards to radiological, clinical and operative aspects. Here, we attemp...

Download PDF file
  • EP ID EP241567
  • DOI -
  • Views 97
  • Downloads 0

How To Cite

Sanchita Karmakar, Hemant Deshpande (2016). Ormeloxifene- A new treatment modality in Dysfunctional Uterine Bleeding: efficacy and safety. Indian Journal of Obstetrics and Gynecology Research, 3(3), 225-228. https://europub.co.uk/articles/-A-241567